Pfizer Inc. (PFE) is expected to report Q2 earnings before market open Wednesday July 23, with a conference call scheduled for July 23 at 11:00 am ET.
Analysts are looking for a profit of 54c on revenue of $11.46B. The consensus range is 49c to 58c for EPS, and revenue of $10.87B to $12.00B, according to First Call.
Possible EPS drivers include increased international sales of Lyrica and Celebrex in conjunction with a weakened dollar and Pfizer's attention to cost cutting. Negative trends that could effect this earning's period include generic competition and weaker Lipitor prescriptions, which accounted for 25% of FY08 revenue. On July 18, Citigroup noted that the company needs additional costs cuts to offset the weakness in the U.S. The firm has a Hold rating and and $18 price target on the shares.